Radiofrequency Ablation (RFA)
Treatment for Liver Cancer Due To Hepatitis C
Effectiveness
80%
Safety Score
65%
Clinical Trials
200
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate (tumor destruction)
Treatment Duration
One-time procedure, may require repeat, followed by surveillance
Evidence Quality
HIGHConfidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$3,000
Side Effect Mgmt:$750
Total Annual:$3,750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$60,000/QALY
QALYs Gained
4
Comparison vs Surgical Resection
Cost Difference
$-70,000/year
Less expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Radiofrequency Ablation (RFA) Outcomes
for Liver Cancer Due To Hepatitis C
Efficacy Outcomes
Overall Effectiveness
+80%
Remission Rate
+70%
Common Side Effects
Pain
+40%
Fever
+30%
Bleeding
+3%
Infection
+2%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov